Onivyde
4.3 mg/mL · Injection, Powder, for Solution
- Prescription only
- Topoisomerase Inhibitor
- Active substance
- Irinotecan Hydrochloride
- Made by
- Ipsen Biopharmaceuticals, Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | Ipsen Biopharmaceuticals, Inc. |
|---|---|
| Active substance | Irinotecan Hydrochloride |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 4.3 mg/mL |
| Form | Injection, Powder, for Solution |
| Route | Intravenous |
| Packs | 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE |
| NDC | 15054-0043 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.